论文部分内容阅读
目的观察奥扎格雷钠联合依达拉奉治疗急性脑梗死的临床疗效。方法选择急性脑梗死患者50例，随机双盲分成治疗组和对照组，治疗组24例给以奥扎格雷钠联合依达拉奉治疗，对照组26例给以奥扎格雷钠治疗，将两组患者在用药前和用药后2周、8周进行美国国立卫生研究院卒中量表NIHSS评分及日常生活活动能力量表Battel指数评定。结果治疗组比对照组有更好的临床疗效，两组比较差异有统计学意义（p<0.05)。结论奥扎格雷钠联合依达拉奉治疗急性脑梗死疗效显著，且对神经功能障碍有良好改善作用。“,”Objective To explore the clinical curative effect in treatment of acute cerebral infarction using Ozagrel-sodium-combine-Edaravane. Methods Choose 50 acute cerebral infarction patient and were randomly divided them into 2 groups, 24 cases in Ozagrel-sodium-combine-Edaravane therapy group(combination therapy group) and 26 cases in control group. Record NIHSS score and evaluation of activities of daily living Battel Index were observed before treatment,2 weeks after treatment and 8 weeks after treatment. Result Combination Objective To explore the clinical curative effect in treatment of acute cerebral infarction using Ozagrel-sodium-combine-Edaravane. Methods Choose 50 acute cerebral infarction patient and were randomly divided them into 2 groups, 24 cases in Ozagrel-sodium-combine-Edaravane therapy group(combination therapy group) and 26 cases in control group. Record NIHSS score and evaluation of activities of daily living Battel Index were observed before treatment,2 weeks after treatment and 8 weeks after treatment. Result Combination therapy group had better clinical effect than control group,the efficacy was significantly different between to groups (p<0.05).Conclusion Ozagrel- sodium -combine-Edaravane is quite effective in treating cerebral infarction ,and it can improve the nerve dysfunction.